Literature DB >> 16830381

Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.

Li Wang1, Fan Zhang, Ping-Ping Wu, Xu-Cheng Jiang, Lin Zheng, Ying-Yan Yu.   

Abstract

AIM: To investigate the distribution of beta-catenin in nuclei or membrane/cytoplasm of gastric carcinoma cells, the relationship between E-cadherin gene methylation and its expression, and the role of beta-catenin and E-cadherin as potential molecular markers in predicting tumor infiltration.
METHODS: Twenty-nine cases of gastric carcinoma, classified as diffuse and intestinal variants, were selected for study. Nuclear and cytoplasmic proteins were purified and beta-catenin content was detected by ELISA. DNA methylation of E-cadherin/CDH1 gene promoter was studied by methylation-specific PCR and compaired with E-cadherin expression detected by immunohistochemistry.
RESULTS: In 27 cases of gastric carcinoma, the ratio of beta-catenin content between nuclei and membrane/cytoplasm was correlated with the T-classification (r = 0.392, P = 0.043). The significance was present between T2 and T3 groups. No correlation was detected between diffuse and intestinal variants in terms of their beta-catenin distribution. In 21 cases of diffuse variants of gastric carcinoma, there was a difference in E-cadherin expression between CDH1 gene-methylated group and non-methylated group (29 % vs 71 %, P = 0.027). No correlation between CDH1 gene methylation and T-classification was found, neither was the significance between E-cadherin expression and tumor infiltration grade.
CONCLUSION: Comparative analysis of nuclear and membrane/cytoplasmic beta-catenin can predict local tumor infiltration. E-cadherin/CDH1 gene methylation is an important cause for its gene silence in diffuse variant gastric carcinoma. Methylation of CDH1 gene in the absence of E-cadherin is an early event in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830381      PMCID: PMC4087380          DOI: 10.3748/wjg.v12.i26.4228

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.

Authors:  T R Devereux; P Stockton; K Sun; R C Sills; N Clayton; M Portier; G Flake
Journal:  Exp Toxicol Pathol       Date:  2001-09

Review 2.  Wnt signaling: a common theme in animal development.

Authors:  K M Cadigan; R Nusse
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

3.  Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.

Authors:  George A Garinis; Panayiotis G Menounos; Nick E Spanakis; Kostas Papadopoulos; George Karavitis; Ismailou Parassi; Evangelia Christeli; George P Patrinos; Evangelos N Manolis; George Peros
Journal:  J Pathol       Date:  2002-12       Impact factor: 7.996

4.  Correlation of beta-catenin and cyclin D1 expression in colon cancers.

Authors:  T Utsunomiya; Y Doki; H Takemoto; H Shiozaki; M Yano; M Sekimoto; S Tamura; T Yasuda; Y Fujiwara; M Monden
Journal:  Oncology       Date:  2001       Impact factor: 2.935

5.  Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.

Authors:  J R Graff; J G Herman; S Myöhänen; S B Baylin; P M Vertino
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 6.  Cancer epigenetics comes of age.

Authors:  P A Jones; P W Laird
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

7.  [Expression of beta-catenin and E-cadherin in early gastric cancer: correlation with clinicopathologic parameters].

Authors:  Byung Joo Song; Young Jin Park; Han Seong Kim; Chul Nam Kim; Seok Hyo Chang
Journal:  Korean J Gastroenterol       Date:  2004-02

8.  Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.

Authors:  Hirohi Saeki; Shinji Tanaka; Keishi Sugimachi; Yasue Kimura; Mitsuhiro Miyazaki; Takefumi Ohga; Keizo Sugimachi
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

9.  Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Makoto Sudo; Ja-Mun Chong; Kazuya Sakuma; Tetsuo Ushiku; Hiroshi Uozaki; Hideo Nagai; Nobuaki Funata; Yoshiro Matsumoto; Masashi Fukayama
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

10.  Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.

Authors:  F Graziano; F Arduini; A Ruzzo; A Mandolesi; I Bearzi; R Silva; P Muretto; E Testa; D Mari; M Magnani; M Scartozzi; S Cascinu
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

View more
  6 in total

1.  Detection of β-catenin, gastrokine-2 and embryonic stem cell expressed ras in gastric cancers.

Authors:  Fan Zhang; Jian Min Tang; Li Wang; Jing Ying Shen; Lin Zheng; Ping Ping Wu; Mei Zhang; Zhao Wen Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-11-01

2.  Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.

Authors:  Dorra Ben Ayed-Guerfali; Basma Hassairi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2013-10-03

3.  Caveolin-1, E-cadherin and β-catenin in Gastric Carcinoma, Precancerous Tissues and Chronic Non-atrophic Gastritis.

Authors:  Guo-Yang Sun; Jun-Xia Wu; Jian-Sheng Wu; Yu-Ting Pan; Rong Jin
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

4.  Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients.

Authors:  Mayumi Mitsuno; Yoshihiko Kitajima; Takao Ide; Kazuma Ohtaka; Masayuki Tanaka; Seiji Satoh; Kohji Miyazaki
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

5.  Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma.

Authors:  Mohammad Reza Zali; Omeed Moaven; Hamid Asadzadeh Aghdaee; Kamran Ghafarzadegan; Khadijeh Jami Ahmadi; Mehdi Farzadnia; Azadeh Arabi; Mohammad Reza Abbaszadegan
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

6.  Progression inference for somatic mutations in cancer.

Authors:  Leif E Peterson; Tatiana Kovyrshina
Journal:  Heliyon       Date:  2017-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.